Lung Cancer clinical trials in El Segundo, CA

1 recruiting lung cancer studies with a site in El Segundo, CA.

All trials in El Segundo, CA · All Lung Cancer trials

RecruitingPhase 3NCT06745908

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

Sponsor: ImmunityBio, Inc.

El Segundo, CA · Fountain Valley, CA · Glendale, CA · +16 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.